Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 15, Issue 5, Pages 277-284
http://dx.doi.org/10.1155/2004/183087
Original Article

An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada

Coleman Rotstein,1 Michel Laverdière,2 Anne Marciniak,3 and Farzad Ali4

1Division of Infectious Diseases, Department of Internal Medicine, McMaster University, Hamilton, Ontario, Canada
2Department of Microbiology-Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada
3Pfizer Ltd, Sandwich, UK
4Pfizer Canada, Kirkland, Quebec, Canada

Received 5 April 2004; Accepted 23 July 2004

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Coleman Rotstein, Michel Laverdière, Anne Marciniak, and Farzad Ali, “An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 15, no. 5, pp. 277-284, 2004. https://doi.org/10.1155/2004/183087.